Sensus Healthcare, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Sensus Healthcare, Inc. (SRTS) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate of 2.50% for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-10.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate · last filed 2020-11-10
- Sensus Healthcare, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2020-03-31 was 2.50%, a 0.00% change year-over-year.
- Sensus Healthcare, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2019-03-31 was 2.50%, a 0.00% change year-over-year.
- Sensus Healthcare, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for the quarter ending 2018-03-31 was 2.50%.
- Sensus Healthcare, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2019 was 2.50%, a 0.00% change from fiscal 2018.
- Sensus Healthcare, Inc. share-based compensation arrangement by share-based payment award, fair value assumptions, risk free interest rate for fiscal 2018 was 2.50%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate 12 month |
|---|---|---|---|---|
| 2020-09-30 | 2.50% 10-Q · filed 2020-11-10 | |||
| 2020-06-30 | 2.50% 10-Q · filed 2020-08-10 | |||
| 2020-03-31 | 2.50% 10-Q · filed 2020-05-11 | |||
| 2019-12-31 | 2.50% 10-K · filed 2020-03-06 | |||
| 2019-09-30 | 2.50% 10-Q · filed 2019-11-08 | |||
| 2019-06-30 | 2.50% 10-Q · filed 2019-08-12 | |||
| 2019-03-31 | 2.50% 10-Q · filed 2019-05-14 | |||
| 2018-12-31 | 2.50% 10-K · filed 2019-03-15 | |||
| 2018-09-30 | 2.50% 10-Q · filed 2018-11-06 | |||
| 2018-06-30 | 2.50% 10-Q · filed 2018-08-14 | |||
| 2018-03-31 | 2.50% 10-Q · filed 2018-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |